REVERSIR Trademark

Trademark Overview


On Friday, October 2, 2015, a trademark application was filed for REVERSIR with the United States Patent and Trademark Office. The USPTO has given the REVERSIR trademark a serial number of 86776831. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 14, 2021. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The REVERSIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-me...
reversir

General Information


Serial Number86776831
Word MarkREVERSIR
Filing DateFriday, October 2, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 14, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 7, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, June 14, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 14, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 30, 2020EXTENSION 5 GRANTED
Wednesday, November 4, 2020EXTENSION 5 FILED
Monday, November 16, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 4, 2020TEAS EXTENSION RECEIVED
Friday, May 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 6, 2020EXTENSION 4 GRANTED
Wednesday, May 6, 2020EXTENSION 4 FILED
Wednesday, May 6, 2020TEAS EXTENSION RECEIVED
Thursday, November 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2019EXTENSION 3 GRANTED
Tuesday, November 5, 2019EXTENSION 3 FILED
Tuesday, November 5, 2019TEAS EXTENSION RECEIVED
Friday, May 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, May 1, 2019EXTENSION 2 GRANTED
Wednesday, May 1, 2019EXTENSION 2 FILED
Wednesday, May 1, 2019TEAS EXTENSION RECEIVED
Tuesday, November 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, November 2, 2018EXTENSION 1 GRANTED
Friday, November 2, 2018EXTENSION 1 FILED
Friday, November 2, 2018TEAS EXTENSION RECEIVED
Tuesday, May 8, 2018NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2018NOTICE OF PUBLICATION
Thursday, February 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 8, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 2, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, August 2, 2016LETTER OF SUSPENSION MAILED
Monday, August 1, 2016SUSPENSION LETTER WRITTEN
Tuesday, July 26, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 26, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 26, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 27, 2016NON-FINAL ACTION MAILED
Saturday, January 23, 2016NON-FINAL ACTION WRITTEN
Friday, January 22, 2016ASSIGNED TO EXAMINER
Wednesday, October 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 6, 2015NEW APPLICATION ENTERED IN TRAM